Delivery Order HHSO100201500009I-HHSO10033001T
Award Date
7/28/16
Potential Completion Date
3/17/23
Potential Value
$7.6M
Ultimate Awardee
University System Of Maryland
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,727,966.00 cost plus fixed fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response to the University of Maryland, Baltimore (UMB) to conduct performance verification of institutional radiation dose response for acute radiation syndrome (ARS) animal models. The contract has no set-aside designation. UMB is performing this work as the prime contractor. This contract supports the agency's mission to enhance national preparedness for...
This is a $11,815,980.00 delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to the University of Maryland, Baltimore (UMB) to test and evaluate Medical Countermeasures (MCMs) in a miniature pig model for Acute Radiation Syndrome (ARS). The contract is a continuation of work under the Biomedical Advanced Research and Development Authority (BARDA) Chem and RadNuc Animal Model 2015-2020 Indefinite...
This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
This is a federal contract award to the University of Maryland, Baltimore (UMB) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract, valued at $63,079,974.98, is for providing product development support services related to medical countermeasures against radiological threats. The contract was awarded on September 30, 2005 and has a completion date of November 21, 2013. There is no set-aside designation for this award,...
This is a $81,904,328.96 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) for radiation/nuclear medical countermeasure product development support services. The contract supports the development of medical countermeasures against radiation and nuclear threats, which aligns with NIAID's mission to conduct and support research to...
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
This is a $7,143,498.00 Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The contract, which does not have a set-aside designation, runs through September 29, 2028. Under this contract, UMB will provide a range of research, education, and clinical services to support NIAID's mission, leveraging the university's...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Maryland, Baltimore (UMB) in the amount of $15,000.00. The contract does not have a set-aside designation. UMB, a major public research university, provides a wide range of goods and services to the federal government, including biomedical and clinical research, healthcare services, and professional education and training. This contract award likely...
This is a $3,603,949.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The contract supports vaccine and treatment evaluation activities, which is a major program of NIAID. There was no set-aside designation for this award. UMB, the prime contractor, is a leading public research university that...
This is a $879,424.00 firm fixed-price service agreement contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to the University of Maryland, Baltimore (UMB) on February 28, 2017. The contract has a base year period of performance ending on February 28, 2020, with no set-aside designation. UMB is providing services under this contract, which is part of a larger $6 million Blanket Purchase Agreement with the Department of Veterans Affairs for reagents, supplies,...